Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristicsMehdi Hamadani, Peter Dreger, Maud Ngoya et al.|Blood Advances|2021Cited by 47
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Enrico Maffini, Mohamad Mohty, Maud Ngoya et al.|Bone Marrow Transplantation|2023Cited by 19
Impact of conditioning regimen on outcomes of adolescents and young adults AML patients undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. a study from the acute leukemia working party of the european society for blood and marrow transplantation.Enrico Maffini, Mohamad Mohty, Maud Ngoya et al.|Blood|2025Cited by 1
Allogeneic Hematopoietic Stem Cell Transplantation Achieves Long-Term Survival in Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working PartyPhilipp Berning, Bertram Glaß, Dai‐Hong Liu et al.|Blood|2022Cited by 0
S225: ALLOGENEIC STEM CELL TRANSPLANTATION FOR NK/T-CELL LYMPHOMA IN THE ERA OF ASPARAGINASE-BASED CHEMOTHERAPY: A RETROSPECTIVE ANALYSIS OF THE EBMT LYMPHOMA WORKING PARTYPhilipp Berning, Bertram Glaß, Norbert Schmitz et al.|HemaSphere|2023Cited by 0